Please use the Back button to return to your page of origin, or go directly to STD Surveillance 2004 Table of Contents.

Table A4. Government Performance Results Act (GPRA) Sexually Transmitted Diseases Goals and Measures

GPRA Goals Baseline Annual Target Actual Performance Long-Term Goal
  2002 2004 2004 2010
Goal 1: Reduction in PID (as measured by initial visits to physicians in women 15-44 years of age) 197,000   163,000   132,000   168,000
      a. Prevalence of Chlamydia in high-risk women ≤ 25 years 10.1%*   9.1%*   9.7%*   8.6%*
      b. Prevalence of Chlamydia in women ≤ 25 years in family planning clinics 5.6%*   5.2%*   6.3%*   4.9%*
      c. Incidence of Gonorrhea/100,000 population in women 15-44 years of age 279   252   278   237

Goal 2: Elimination of Syphilis (as measured by incidence of P&S Syphilis/100,000 population)
2.4   2.5   2.7   2.2
      a. Incidence of P&S Syphilis/100,000 population - men 3.8   4.5   4.7   4.2
      b. Incidence of P&S Syphilis/100,000 population - women 1.1   0.5   0.8   0.38
      c. Incidence of Congenital Syphilis/100,000 live births 10.2   5.4   8.8   3.9
      d. Black:white rate ratio of P&S Syphilis 8:1   3.5:1   5.6:1   3:1

 

GPRA Goals Data Source
1 National Disease and Therapeutic Index (IMS Health).
1a National Job Training Program.
1b STD Surveillance System (STDSS), CDC, NCHSTP.
1c STD Surveillance System (STDSS), CDC, NCHSTP.
2 STD Surveillance System (STDSS), CDC, NCHSTP.
2a STD Surveillance System (STDSS), CDC, NCHSTP.
2b STD Surveillance System (STDSS), CDC, NCHSTP.
2c STD Surveillance System (STDSS), CDC, NCHSTP.
2d STD Surveillance System (STDSS), CDC, NCHSTP.

*Median state-specific chlamydia prevalence among women was not adjusted for changes in laboratory test method and associated increases in test sensitivity.

 

Page last modified: November 8, 2005
Page last reviewed: November 8, 2005 Historical Document

Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention